# Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma Patients

> **NCT01366118** · NA · COMPLETED · sponsor: **Grupo Hospital de Madrid** · enrollment: 16 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Therapeutic target tailored chemotherapy

## Key facts

- **NCT ID:** NCT01366118
- **Lead sponsor:** Grupo Hospital de Madrid
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366118, "Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01366118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*